{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:40:48Z","timestamp":1788932448520,"version":"build-2803163510"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41556-026-01871-6","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:03:31Z","timestamp":1770890611000},"page":"492-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Glucosylceramide-induced ectosomes propagate pathogenic \u03b1-synuclein in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"28","author":[{"given":"Julie","family":"Jacquemyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0420-2340","authenticated-orcid":false,"given":"Ehlam","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedi","family":"Chik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael Y. J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Rubio Atonal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceili","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1010-1114","authenticated-orcid":false,"given":"Jeremy","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Acevedo-Morantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol X.-Q.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nicouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Deneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Abdian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-1956","authenticated-orcid":false,"given":"Thomas M.","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6252-8626","authenticated-orcid":false,"given":"Maria S.","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"1871_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/nan.12592","volume":"46","author":"Z Jaunmuktane","year":"2020","unstructured":"Jaunmuktane, Z. & Brandner, S. Invited review: the role of prion-like mechanisms in neurodegenerative diseases. Neuropathol. Appl. Neurobiol. 46, 522\u2013545 (2020).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1871_CR2","doi-asserted-by":"publisher","first-page":"105307","DOI":"10.1016\/j.neuint.2022.105307","volume":"155","author":"S Yoshida","year":"2022","unstructured":"Yoshida, S. & Hasegawa, T. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases. Neurochem. Int. 155, 105307 (2022).","journal-title":"Neurochem. Int."},{"key":"1871_CR3","doi-asserted-by":"crossref","unstructured":"Calabresi, P. et al. \u03b1-Synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell. Death Dis. 14, 176 (2023).","DOI":"10.1038\/s41419-023-05672-9"},{"key":"1871_CR4","doi-asserted-by":"publisher","first-page":"1137893","DOI":"10.3389\/fnins.2023.1137893","volume":"17","author":"X Pan","year":"2023","unstructured":"Pan, X., Dutta, D., Lu, S. & Bellen, H. J. Sphingolipids in neurodegenerative diseases. Front. Neurosci. 17, 1137893 (2023).","journal-title":"Front. Neurosci."},{"key":"1871_CR5","doi-asserted-by":"crossref","unstructured":"Fanning, S., Selkoe, D. & Dettmer, U. Parkinson\u2019s disease: proteinopathy or lipidopathy? NPJ Parkinsons Dis. 6, 3 (2020).","DOI":"10.1038\/s41531-019-0103-7"},{"key":"1871_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu, I. & Bennett, S. A. L. Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease. Front. Neurosci. 13, 1\u201322 (2019).","journal-title":"Front. Neurosci."},{"key":"1871_CR7","doi-asserted-by":"crossref","unstructured":"Fanning, S. & Selkoe, D. Parkinson disease is a fatty acidopathy. Nat. Rev. Neurol. 21, 642\u2013655 (2025).","DOI":"10.1038\/s41582-025-01142-2"},{"key":"1871_CR8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky, E. et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N. Engl. J. Med. 361, 1651\u20131661 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1871_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jnc.13385","volume":"139","author":"A Migdalska-Richards","year":"2016","unstructured":"Migdalska-Richards, A. & Schapira, A. H. V. The relationship between glucocerebrosidase mutations and Parkinson disease. J. Neurochem. 139, 77\u201390 (2016).","journal-title":"J. Neurochem."},{"key":"1871_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","volume":"70","author":"MA Nalls","year":"2013","unstructured":"Nalls, M. A. et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol. 70, 727\u2013735 (2013).","journal-title":"JAMA Neurol."},{"key":"1871_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0021-9258(18)97611-8","volume":"240","author":"R Brady","year":"1965","unstructured":"Brady, R., Kanfer, J. & Shapiro, D. The metabolism of glucocerebrosides. J. Biol. Chem. 240, 39\u201343 (1965).","journal-title":"J. Biol. Chem."},{"key":"1871_CR12","doi-asserted-by":"crossref","unstructured":"Leyns, C. E. G. et al. Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson\u2019s disease. NPJ Parkinsons Dis. 9, 74 (2023).","DOI":"10.1038\/s41531-023-00517-w"},{"key":"1871_CR13","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","volume":"36","author":"JR Mazzulli","year":"2016","unstructured":"Mazzulli, J. R. et al. Activation of \u03b2-glucocerebrosidase reduces pathological \u03b1-synuclein and restores lysosomal function in Parkinson\u2019s patient midbrain neurons. J. Neurosci. 36, 7693\u20137706 (2016).","journal-title":"J. Neurosci."},{"key":"1871_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli, J. R. et al. Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146, 37\u201352 (2011).","journal-title":"Cell"},{"key":"1871_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuron.2017.12.012","volume":"97","author":"F Zunke","year":"2018","unstructured":"Zunke, F. et al. Reversible conformational conversion of \u03b1-synuclein into toxic assemblies by glucosylceramide. Neuron 97, 92\u2013107 (2018).","journal-title":"Neuron"},{"key":"1871_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aau6870","volume":"11","author":"LF Burbulla","year":"2019","unstructured":"Burbulla, L. F. et al. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson\u2019s disease. Sci. Transl. Med. 11, 1\u201311 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1871_CR17","doi-asserted-by":"crossref","unstructured":"Sch\u00f6ndorf, D. C. et al. IPSC-derived neurons from GBA1-associated Parkinson\u2019s disease patients show autophagic defects and impaired calcium homeostasis. Nat. Commun. 5, 4028 (2014).","DOI":"10.1038\/ncomms5028"},{"key":"1871_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1523\/JNEUROSCI.0680-22.2022","volume":"43","author":"CL Mahoney-Crane","year":"2023","unstructured":"Mahoney-Crane, C. L. et al. Neuronopathic GBA1L444P mutation accelerates glucosylsphingosine levels and formation of hippocampal \u03b1-synuclein inclusions. J. Neurosci. 43, 501\u2013521 (2023).","journal-title":"J. Neurosci."},{"key":"1871_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","volume":"14","author":"M Huebecker","year":"2019","unstructured":"Huebecker, M. et al. Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson\u2019s disease. Mol. Neurodegener. 14, 40 (2019).","journal-title":"Mol. Neurodegener."},{"key":"1871_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/cells11081353","volume":"11","author":"A Esfandiary","year":"2022","unstructured":"Esfandiary, A., Finkelstein, D. I., Voelcker, N. H. & Rudd, D. Clinical sphingolipids pathway in Parkinson\u2019s disease: from GCase to integrated-biomarker discovery. Cells 11, 1353 (2022).","journal-title":"Cells"},{"key":"1871_CR21","doi-asserted-by":"publisher","first-page":"e73094","DOI":"10.1371\/journal.pone.0073094","volume":"8","author":"MM Mielke","year":"2013","unstructured":"Mielke, M. M. et al. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson\u2019s disease and associated with cognitive impairment: a pilot study. PLoS ONE 8, e73094 (2013).","journal-title":"PLoS ONE"},{"key":"1871_CR22","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1073\/pnas.1717590115","volume":"115","author":"M Nguyen","year":"2018","unstructured":"Nguyen, M. & Krainc, D. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson\u2019s disease. Proc. Natl Acad. Sci. USA 115, 5576\u20135581 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1871_CR23","doi-asserted-by":"crossref","unstructured":"Ysselstein, D. et al. LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients. Nat. Commun. 10, 5570 (2019).","DOI":"10.1038\/s41467-019-13413-w"},{"key":"1871_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2017.08.026","volume":"44","author":"LC Guedes","year":"2017","unstructured":"Guedes, L. C. et al. Serum lipid alterations in GBA-associated Parkinson\u2019s disease. Parkinsonism Relat. Disord. 44, 58\u201365 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1871_CR25","doi-asserted-by":"publisher","first-page":"788695","DOI":"10.3389\/fnmol.2021.788695","volume":"14","author":"RE Estes","year":"2021","unstructured":"Estes, R. E., Lin, B., Khera, A. & Davis, M. Y. Lipid metabolism influence on neurodegenerative disease progression: is the vehicle as important as the cargo? Front. Mol. Neurosci. 14, 788695 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"1871_CR26","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"1871_CR27","doi-asserted-by":"publisher","first-page":"jcs260887","DOI":"10.1242\/jcs.260887","volume":"136","author":"K Sapon","year":"2023","unstructured":"Sapon, K., Manka, R., Janas, T. & Janas, T. The role of lipid rafts in vesicle formation. J. Cell Sci. 136, jcs260887 (2023).","journal-title":"J. Cell Sci."},{"key":"1871_CR28","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin, D. L. et al. Lipid rafts mediate the synaptic localization of \u03b1-synuclein. J. Neurosci. 24, 6715\u20136723 (2004).","journal-title":"J. Neurosci."},{"key":"1871_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jmb.2011.03.009","volume":"408","author":"J Fantini","year":"2011","unstructured":"Fantini, J. & Yahi, N. Molecular basis for the glycosphingolipid-binding specificity of \u03b1-synuclein: key role of tyrosine 39 in membrane insertion. J. Mol. Biol. 408, 654\u2013669 (2011).","journal-title":"J. Mol. Biol."},{"key":"1871_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1126\/science.1174621","volume":"327","author":"D Lingwood","year":"2010","unstructured":"Lingwood, D. & Simons, K. Lipid rafts as a membrane-organizing principle. Science 327, 46\u201350 (2010).","journal-title":"Science"},{"key":"1871_CR31","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.bbamem.2011.06.017","volume":"1808","author":"J Fantini","year":"2011","unstructured":"Fantini, J., Carlus, D. & Yahi, N. The fusogenic tilted peptide (67-78) of \u03b1-synuclein is a cholesterol binding domain. Biochim. Biophys. Acta Biomembr. 1808, 2343\u20132351 (2011).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"1871_CR32","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","volume":"37","author":"YV Taguchi","year":"2017","unstructured":"Taguchi, Y. V. et al. Glucosylsphingosine promotes \u03b1-synuclein pathology in mutant GBA-associated parkinson\u2019s disease. J. Neurosci. 37, 9617\u20139631 (2017).","journal-title":"J. Neurosci."},{"key":"1871_CR33","doi-asserted-by":"publisher","first-page":"eabn3326","DOI":"10.1126\/sciadv.abn3326","volume":"8","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Neuronal activity induces glucosylceramide that is secreted via exosomes for lysosomal degradation in glia. Sci. Adv. 8, eabn3326 (2022).","journal-title":"Sci. Adv."},{"key":"1871_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1871_CR35","first-page":"55","volume":"13","author":"H Sugiyama","year":"1994","unstructured":"Sugiyama, H., Hainfellner, J. A., Yoshimura, M. & Budka, H. Neocortical changes in Parkinson\u2019s disease, revisited. Clin. Neuropathol. 13, 55\u201359 (1994).","journal-title":"Clin. Neuropathol."},{"key":"1871_CR36","doi-asserted-by":"crossref","unstructured":"Feliciano, D. et al. YAP1 nuclear efflux and transcriptional reprograming follow membrane diminution upon VSV-G-induced cell fusion. Nat. Commun. 12, 4502 (2021).","DOI":"10.1038\/s41467-021-24708-2"},{"key":"1871_CR37","first-page":"312","volume":"1","author":"J Gao","year":"2009","unstructured":"Gao, J., Liao, J. & Yang, G.-Y. Review article CAAX-box protein, prenylation process and carcinogenesis. Am. J. Transl. Res. 1, 312\u2013325 (2009).","journal-title":"Am. J. Transl. Res."},{"key":"1871_CR38","doi-asserted-by":"publisher","first-page":"e12309","DOI":"10.1002\/jev2.12309","volume":"12","author":"K Broad","year":"2023","unstructured":"Broad, K. et al. Unraveling multilayered extracellular vesicles: speculation on cause. J. Extracell. Vesicles 12, e12309 (2023).","journal-title":"J. Extracell. Vesicles"},{"key":"1871_CR39","doi-asserted-by":"crossref","unstructured":"Matthies, D. et al. Microdomains form on the luminal face of neuronal extracellular vesicle membranes. Sci. Rep. 10, 11953 (2020).","DOI":"10.1038\/s41598-020-68436-x"},{"key":"1871_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0009-8981(80)90168-0","volume":"106","author":"LB Daniels","year":"1980","unstructured":"Daniels, L. B., Glew, R. H., Radin, N. S. & Vunnam, R. R. A revised fluorometric assay for Gaucher\u2019s disease using conduritol-beta-epoxide with livers as the source of beta-glucosidase. Clin. Chim. Acta 106, 155\u2013163 (1980).","journal-title":"Clin. Chim. Acta"},{"key":"1871_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.tins.2024.02.008","volume":"47","author":"TS Zimmer","year":"2024","unstructured":"Zimmer, T. S., Orr, A. L. & Orr, A. G. Astrocytes in selective vulnerability to neurodegenerative disease. Trends Neurosci. 47, 289\u2013302 (2024).","journal-title":"Trends Neurosci."},{"key":"1871_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40035-021-00265-y","volume":"10","author":"C Wang","year":"2021","unstructured":"Wang, C., Yang, T., Liang, M., Xie, J. & Song, N. Astrocyte dysfunction in Parkinson\u2019s disease: from the perspectives of transmitted \u03b1-synuclein and genetic modulation. Transl. Neurodegener. 10, 39 (2021).","journal-title":"Transl. Neurodegener."},{"key":"1871_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","volume":"20","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 20, 332\u2013343 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1871_CR44","doi-asserted-by":"publisher","first-page":"e100760","DOI":"10.1371\/journal.pone.0100760","volume":"9","author":"S Dujardin","year":"2014","unstructured":"Dujardin, S. et al. Ectosomes: a new mechanism for non-exosomal secretion of Tau protein. PLoS ONE 9, e100760 (2014).","journal-title":"PLoS ONE"},{"key":"1871_CR45","doi-asserted-by":"publisher","first-page":"102919","DOI":"10.1016\/j.scr.2022.102919","volume":"64","author":"CX-Q Chen","year":"2022","unstructured":"Chen, C. X.-Q. et al. Generation of patient-derived pluripotent stem cell-lines and CRISPR modified isogenic controls with mutations in the Parkinson\u2019s associated GBA gene. Stem Cell Res. 64, 102919 (2022).","journal-title":"Stem Cell Res."},{"key":"1871_CR46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ymeth.2021.09.002","volume":"203","author":"E Deneault","year":"2022","unstructured":"Deneault, E. et al. A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis. Methods 203, 297\u2013310 (2022).","journal-title":"Methods"},{"key":"1871_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0304-3940(99)00208-6","volume":"265","author":"H Braak","year":"1999","unstructured":"Braak, H., Sandmann-Keil, D., Gai, W. & Braak, E. Extensive axonal Lewy neurites in Parkinson\u2019s disease: a novel pathological feature revealed by \u03b1-synuclein immunocytochemistry. Neurosci. Lett. 265, 67\u201369 (1999).","journal-title":"Neurosci. Lett."},{"key":"1871_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.06.025","volume":"56","author":"GW O\u2019Keeffe","year":"2018","unstructured":"O\u2019Keeffe, G. W. & Sullivan, A. M. Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 56, 9\u201315 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1871_CR49","doi-asserted-by":"crossref","unstructured":"Mathieu, M. et al. Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat. Commun. 12, 4389 (2021).","DOI":"10.1038\/s41467-021-24384-2"},{"key":"1871_CR50","doi-asserted-by":"publisher","first-page":"e2211368120","DOI":"10.1073\/pnas.2211368120","volume":"120","author":"A Kvalvaag","year":"2023","unstructured":"Kvalvaag, A. et al. Clathrin mediates both internalization and vesicular release of triggered T cell receptor at the immunological synapse. Proc. Natl Acad. Sci. USA 120, e2211368120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1871_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12860-024-00504-w","volume":"25","author":"M Shaver","year":"2024","unstructured":"Shaver, M., Gomez, K., Kaiser, K. & Hutcheson, J. D. Mechanical stretch leads to increased caveolin-1 content and mineralization potential in extracellular vesicles from vascular smooth muscle cells. BMC Mol. Cell Biol. 25, 8 (2024).","journal-title":"BMC Mol. Cell Biol."},{"key":"1871_CR52","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1021\/jm300063b","volume":"55","author":"S Patnaik","year":"2012","unstructured":"Patnaik, S. et al. Discovery, structure\u2013activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase. J. Med. Chem. 55, 5734\u20135748 (2012).","journal-title":"J. Med. Chem."},{"key":"1871_CR53","doi-asserted-by":"publisher","first-page":"240ra73","DOI":"10.1126\/scitranslmed.3008659","volume":"6","author":"E Aflaki","year":"2014","unstructured":"Aflaki, E. et al. Macrophage models of gaucher disease for evaluating disease pathogenesis and candidate drugs. Sci. Transl. Med. 6, 240ra73 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1871_CR54","doi-asserted-by":"publisher","first-page":"107023","DOI":"10.1016\/j.parkreldis.2024.107023","volume":"124","author":"M Marano","year":"2024","unstructured":"Marano, M. et al. Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson\u2019s disease. Parkinsonism Relat. Disord. 124, 107023 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1871_CR55","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/brain\/awab371","volume":"145","author":"C Galvagnion","year":"2022","unstructured":"Galvagnion, C. et al. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote \u03b1-synuclein aggregation. Brain 145, 1038\u20131051 (2022).","journal-title":"Brain"},{"key":"1871_CR56","doi-asserted-by":"publisher","first-page":"116179","DOI":"10.1016\/j.celrep.2025.116179","volume":"44","author":"M Samaddar","year":"2025","unstructured":"Samaddar, M. et al. Lysosomal polyamine storage upon ATP13A2 loss impairs \u03b2-glucocerebrosidase via altered lysosomal pH and electrostatic hydrolase-lipid interactions. Cell Rep. 44, 116179 (2025).","journal-title":"Cell Rep."},{"key":"1871_CR57","doi-asserted-by":"crossref","unstructured":"Realini, N. et al. Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity. Sci. Rep. 3, 1035 (2013).","DOI":"10.1038\/srep01035"},{"key":"1871_CR58","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1021\/acs.jmedchem.8b01723","volume":"62","author":"A Dementiev","year":"2019","unstructured":"Dementiev, A. et al. Molecular mechanism of inhibition of acid ceramidase by carmofur. J. Med. Chem. 62, 987\u2013992 (2019).","journal-title":"J. Med. Chem."},{"key":"1871_CR59","doi-asserted-by":"crossref","unstructured":"Viel, C. et al. Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model. Sci. Rep. 11, 20945 (2021).","DOI":"10.1038\/s41598-021-00404-5"},{"key":"1871_CR60","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s00018-024-05419-5","volume":"81","author":"L Dai","year":"2024","unstructured":"Dai, L. et al. Lysosomal dysfunction in \u03b1-synuclein pathology: molecular mechanisms and therapeutic strategies. Cell. Mol. Life Sci. 81, 382 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"1871_CR61","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fnins.2020.00442","volume":"14","author":"A Sanyal","year":"2020","unstructured":"Sanyal, A., Novis, H. S., Gasser, E., Lin, S. & LaVoie, M. J. LRRK2 kinase inhibition rescues deficits in lysosome function due to heterozygous GBA1 expression in human iPSC-derived neurons. Front. Neurosci. 14, 442 (2020).","journal-title":"Front. Neurosci."},{"key":"1871_CR62","doi-asserted-by":"publisher","first-page":"e40048","DOI":"10.7554\/eLife.40048","volume":"7","author":"X Xian","year":"2018","unstructured":"Xian, X. et al. Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer\u2019s disease. eLife 7, e40048 (2018).","journal-title":"eLife"},{"key":"1871_CR63","doi-asserted-by":"publisher","unstructured":"Tejwani, L. et al. Lysosomes cell autonomously regulate myeloid cell states and immune responses. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.11.11.623074 (2024).","DOI":"10.1101\/2024.11.11.623074"},{"key":"1871_CR64","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/jpet.115.227587","volume":"355","author":"MJ Fell","year":"2015","unstructured":"Fell, M. J. et al. MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase inhibition. J. Pharmacol. Exp. Ther. 355, 397\u2013409 (2015).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1871_CR65","doi-asserted-by":"publisher","first-page":"111102","DOI":"10.1016\/j.celrep.2022.111102","volume":"40","author":"A Bayati","year":"2022","unstructured":"Bayati, A. et al. Rapid macropinocytic transfer of \u03b1-synuclein to lysosomes. Cell. Rep. 40, 111102 (2022).","journal-title":"Cell. Rep."},{"key":"1871_CR66","doi-asserted-by":"crossref","unstructured":"Xie, Y. X. et al. Lysosomal exocytosis releases pathogenic \u03b1-synuclein species from neurons in synucleinopathy models. Nat. Commun. 13, 4918 (2022).","DOI":"10.1038\/s41467-022-32625-1"},{"key":"1871_CR67","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.3233\/JPD-223516","volume":"12","author":"IC Br\u00e1s","year":"2022","unstructured":"Br\u00e1s, I. C. et al. Molecular mechanisms mediating the transfer of disease-associated proteins and effects on neuronal activity. J. Parkinsons Dis. 12, 2397\u20132422 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1871_CR68","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804\u201315 (1988).","journal-title":"J. Neurosci."},{"key":"1871_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"1871_CR70","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Y. Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite-like aggregates. Nat. Protoc. 9, 2135\u20132146 (2014).","journal-title":"Nat. Protoc."},{"key":"1871_CR71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski, N. K. et al. Best practices for generating and using \u03b1-synuclein pre-formed fibrils to model Parkinson\u2019s disease in rodents. J. Parkinsons Dis. 8, 303\u2013322 (2018).","journal-title":"J. Parkinsons Dis."},{"key":"1871_CR72","doi-asserted-by":"crossref","unstructured":"Ma, M. R., Hu, Z. W., Zhao, Y. F., Chen, Y. X. & Li, Y. M. Phosphorylation induces distinct \u03b1-synuclein strain formation. Sci. Rep. 6, 37130 (2016).","DOI":"10.1038\/srep37130"},{"key":"1871_CR73","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic lewy body disease. J. Biol. Chem. 281, 29739\u201329752 (2006).","journal-title":"J. Biol. Chem."},{"key":"1871_CR74","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell. Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell. Biol."},{"key":"1871_CR75","doi-asserted-by":"publisher","first-page":"41128","DOI":"10.1074\/jbc.M206747200","volume":"277","author":"C Luberto","year":"2002","unstructured":"Luberto, C. et al. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J. Biol. Chem. 277, 41128\u201341139 (2002).","journal-title":"J. Biol. Chem."},{"key":"1871_CR76","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244\u20131247 (2008).","journal-title":"Science"},{"key":"1871_CR77","doi-asserted-by":"publisher","first-page":"612","DOI":"10.20517\/cdr.2022.26","volume":"5","author":"A Kumar","year":"2022","unstructured":"Kumar, A. et al. Role of extracellular vesicles secretion in paclitaxel resistance of prostate cancer cells. Cancer Drug Resist. 5, 612\u2013624 (2022).","journal-title":"Cancer Drug Resist."},{"key":"1871_CR78","doi-asserted-by":"publisher","first-page":"1378056","DOI":"10.1080\/20013078.2017.1378056","volume":"6","author":"K Menck","year":"2017","unstructured":"Menck, K. et al. Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane. J. Extracell. Vesicles 6, 1378056 (2017).","journal-title":"J. Extracell. Vesicles"},{"key":"1871_CR79","doi-asserted-by":"crossref","unstructured":"Rojas, C. et al. DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation. Sci. Rep. 8, 17715 (2018).","DOI":"10.1038\/s41598-018-36144-2"},{"key":"1871_CR80","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s10571-018-0622-5","volume":"38","author":"G Gustafsson","year":"2018","unstructured":"Gustafsson, G. et al. Secretion and uptake of \u03b1-synuclein via extracellular vesicles in cultured cells. Cell. Mol. Neurobiol. 38, 1539\u20131550 (2018).","journal-title":"Cell. Mol. Neurobiol."},{"key":"1871_CR81","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00401-021-02367-3","volume":"142","author":"M Kurzawa-Akanbi","year":"2021","unstructured":"Kurzawa-Akanbi, M. et al. Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of \u03b1-synuclein in Lewy body disorders. Acta Neuropathol. 142, 961\u2013984 (2021).","journal-title":"Acta Neuropathol."},{"key":"1871_CR82","doi-asserted-by":"publisher","first-page":"15560","DOI":"10.1073\/pnas.2536699100","volume":"100","author":"A Duffield","year":"2003","unstructured":"Duffield, A., Kamsteeg, E.-J., Brown, A. N., Pagel, P. & Caplan, M. J. The tetraspanin CD63 enhances the internalization of the H,K-ATPase-subunit. Proc. Natl Acad. Sci. USA 100, 15560\u201315565 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1871_CR83","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1093\/brain\/aww237","volume":"139","author":"Y Iguchi","year":"2016","unstructured":"Iguchi, Y. et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139, 3187\u20133201 (2016).","journal-title":"Brain"},{"key":"1871_CR84","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.celrep.2017.12.009","volume":"22","author":"YR Choi","year":"2018","unstructured":"Choi, Y. R. et al. Prion-like propagation of \u03b1-synuclein is regulated by the Fc\u03b3RIIB-SHP-1\/2 signaling pathway in neurons. Cell. Rep. 22, 136\u2013148 (2018).","journal-title":"Cell. Rep."},{"key":"1871_CR85","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ceb.2021.03.003","volume":"71","author":"C Zurzolo","year":"2021","unstructured":"Zurzolo, C. Tunneling nanotubes: reshaping connectivity. Curr. Opin. Cell Biol. 71, 139\u2013147 (2021).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1871_CR86","doi-asserted-by":"publisher","first-page":"e939","DOI":"10.1002\/cpz1.939","volume":"3","author":"I S\u00e1enz-De-Santa-Mar\u00eda","year":"2023","unstructured":"S\u00e1enz-De-Santa-Mar\u00eda, I., Henderson, M., Pepe, A. & Zurzolo, C. Identification and characterization of tunneling nanotubes for intercellular trafficking. Curr. Protoc. 3, e939 (2023).","journal-title":"Curr. Protoc."},{"key":"1871_CR87","doi-asserted-by":"publisher","first-page":"e3001287","DOI":"10.1371\/journal.pbio.3001287","volume":"19","author":"AD Senol","year":"2021","unstructured":"Senol, A. D. et al. A-synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes. PLoS Biol. 19, e3001287 (2021).","journal-title":"PLoS Biol."},{"key":"1871_CR88","doi-asserted-by":"crossref","unstructured":"Dieriks, B. V. et al. \u03b1-Synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson\u2019s disease patients. Sci. Rep. 7, 42984 (2017).","DOI":"10.1038\/srep42984"},{"key":"1871_CR89","doi-asserted-by":"publisher","first-page":"eadr7403","DOI":"10.1126\/science.adr7403","volume":"390","author":"M Chang","year":"2025","unstructured":"Chang, M. et al. Intercellular communication in the brain through a dendritic nanotubular network. Science 390, eadr7403 (2025).","journal-title":"Science"},{"key":"1871_CR90","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ymgme.2017.05.010","volume":"121","author":"LK Hein","year":"2017","unstructured":"Hein, L. K., Rozaklis, T., Adams, M. K., Hopwood, J. J. & Karageorgos, L. Lipid composition of microdomains is altered in neuronopathic Gaucher disease sheep brain and spleen. Mol. Genet. Metab. 121, 259\u2013270 (2017).","journal-title":"Mol. Genet. Metab."},{"key":"1871_CR91","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bbrc.2013.11.009","volume":"442","author":"KJ Hattersley","year":"2013","unstructured":"Hattersley, K. J., Hein, L. K. & Fuller, M. Lipid composition of membrane rafts, isolated with and without detergent, from the spleen of a mouse model of Gaucher disease. Biochem. Biophys. Res. Commun. 442, 62\u201367 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1871_CR92","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/hmg\/ddy105","volume":"27","author":"MJ Kim","year":"2018","unstructured":"Kim, M. J., Jeon, S., Burbulla, L. F. & Krainc, D. Acid ceramidase inhibition ameliorates \u03b1-synuclein accumulation upon loss of GBA1 function. Hum. Mol. Genet. 27, 1972\u20131988 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"1871_CR93","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.bbamem.2012.11.018","volume":"1828","author":"ARP Varela","year":"2013","unstructured":"Varela, A. R. P. et al. Effect of glucosylceramide on the biophysical properties of fluid membranes. Biochim. Biophys. Acta Biomembr. 1828, 1122\u20131130 (2013).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"1871_CR94","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.15252\/embj.201592484","volume":"34","author":"JH Hurley","year":"2015","unstructured":"Hurley, J. H. ESCRTs are everywhere. EMBO J. 34, 2398\u20132407 (2015).","journal-title":"EMBO J."},{"key":"1871_CR95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40035-023-00362-0","volume":"12","author":"CH Lo","year":"2023","unstructured":"Lo, C. H. & Zeng, J. Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases. Transl. Neurodegener. 12, 29 (2023).","journal-title":"Transl. Neurodegener."},{"key":"1871_CR96","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.arr.2016.05.004","volume":"32","author":"DJ Colacurcio","year":"2016","unstructured":"Colacurcio, D. J. & Nixon, R. A. Disorders of lysosomal acidification\u2014the emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res. Rev. 32, 75\u201388 (2016).","journal-title":"Ageing Res. Rev."},{"key":"1871_CR97","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neuint.2011.05.017","volume":"59","author":"A Madeira","year":"2011","unstructured":"Madeira, A. et al. Caveolin-1 interacts with \u03b1-synuclein and mediates toxic actions of cellular \u03b1-synuclein overexpression. Neurochem. Int. 59, 280\u2013289 (2011).","journal-title":"Neurochem. Int."},{"key":"1871_CR98","doi-asserted-by":"publisher","first-page":"105091","DOI":"10.1016\/j.jbc.2023.105091","volume":"299","author":"KJ Vargas","year":"2023","unstructured":"Vargas, K. J. et al. \u03b1-Synuclein colocalizes with AP180 and affects the size of clathrin lattices. J. Biol. Chem. 299, 105091 (2023).","journal-title":"J. Biol. Chem."},{"key":"1871_CR99","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuron.2019.12.004","volume":"105","author":"MX Henderson","year":"2020","unstructured":"Henderson, M. X. et al. Glucocerebrosidase activity modulates neuronal susceptibility to pathological \u03b1-synuclein insult. Neuron 105, 822\u2013836 (2020).","journal-title":"Neuron"},{"key":"1871_CR100","doi-asserted-by":"publisher","first-page":"737195","DOI":"10.3389\/fneur.2021.737195","volume":"12","author":"K Malfertheiner","year":"2021","unstructured":"Malfertheiner, K., Stefanova, N. & Heras-Garvin, A. The concept of \u03b1-synuclein strains and how different conformations may explain distinct neurodegenerative disorders. Front. Neurol. 12, 737195 (2021).","journal-title":"Front. Neurol."},{"key":"1871_CR101","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.23614","volume":"72","author":"ME Gegg","year":"2012","unstructured":"Gegg, M. E. et al. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann. Neurol. 72, 455\u2013463 (2012).","journal-title":"Ann. Neurol."},{"key":"1871_CR102","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cmet.2018.05.019","volume":"28","author":"G Lin","year":"2018","unstructured":"Lin, G. et al. Phospholipase PLA2G6, a parkinsonism-associated gene, affects Vps26 and Vps35, retromer function, and ceramide levels, similar to \u03b1-synuclein gain. Cell Metab. 28, 605\u2013618 (2018).","journal-title":"Cell Metab."},{"key":"1871_CR103","doi-asserted-by":"publisher","first-page":"e2025347118","DOI":"10.1073\/pnas.2025347118","volume":"118","author":"M Vos","year":"2021","unstructured":"Vos, M. et al. Ceramide accumulation induces mitophagy and impairs \u03b2-oxidation in PINK1 deficiency. Proc. Natl Acad. Sci. USA 118, e2025347118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1871_CR104","doi-asserted-by":"publisher","first-page":"e20192193","DOI":"10.1084\/jem.20192193","volume":"218","author":"F Bassil","year":"2021","unstructured":"Bassil, F. et al. \u03b1-Synuclein modulates tau spreading in mouse brains. J. Exp. Med. 218, e20192193 (2021).","journal-title":"J. Exp. Med."},{"key":"1871_CR105","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1002\/cpcb.95","volume":"84","author":"MS Ioannou","year":"2019","unstructured":"Ioannou, M. S., Liu, Z. & Lippincott-Schwartz, J. A neuron-glia co-culture system for studying intercellular lipid transport. Curr. Protoc. Cell. Biol. 84, e95 (2019).","journal-title":"Curr. Protoc. Cell. Biol."},{"key":"1871_CR106","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/mps4030050","volume":"4","author":"CXQ Chen","year":"2021","unstructured":"Chen, C. X. Q. et al. A multistep workflow to evaluate newly generated ipscs and their ability to generate different cell types. Methods Protoc. 4, 50 (2021).","journal-title":"Methods Protoc."},{"key":"1871_CR107","doi-asserted-by":"publisher","first-page":"12766.1","DOI":"10.12688\/mniopenres.12766.1","volume":"1","author":"B Ritter","year":"2017","unstructured":"Ritter, B., Ferguson, S. M., De Camilli, P. & Mcpherson, P. S. A lentiviral system for efficient knockdown of proteins in neuronal cultures [version 1; referees: 2 approved]. MNI Open Res. 1, 12766.1 (2017).","journal-title":"MNI Open Res."},{"key":"1871_CR108","doi-asserted-by":"crossref","unstructured":"Sasaki, A., Arawaka, S., Sato, H. & Kato, T. Sensitive western blotting for detection of endogenous Ser129-phosphorylated \u03b1-synuclein in intracellular and extracellular spaces. Sci. Rep. 5, 14211 (2015).","DOI":"10.1038\/srep14211"},{"key":"1871_CR109","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","volume":"92","author":"DGR Tervo","year":"2016","unstructured":"Tervo, D. G. R. et al. A designer AAV variant permits efficient retrograde access to projection neurons. Neuron 92, 372\u2013382 (2016).","journal-title":"Neuron"},{"key":"1871_CR110","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ymgme.2008.01.013","volume":"94","author":"YH Xu","year":"2008","unstructured":"Xu, Y. H. et al. Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid \u03b2-glucosidase residual activity levels. Mol. Genet. Metab. 94, 190\u2013203 (2008).","journal-title":"Mol. Genet. Metab."},{"key":"1871_CR111","doi-asserted-by":"publisher","first-page":"27646","DOI":"10.1073\/pnas.2003021117","volume":"117","author":"O Roed Brekk","year":"2020","unstructured":"Roed Brekk, O., Honey, J. R., Lee, S., Hallett, P. J. & Isacson, O. Cell type-specific lipid storage changes in Parkinson\u2019s disease patient brains are recapitulated by experimental glycolipid disturbance. Proc. Natl Acad. Sci. USA 117, 27646\u201327654 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1871_CR112","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/bioinformatics\/btt276","volume":"29","author":"J Ollion","year":"2013","unstructured":"Ollion, J., Cochennec, J., Loll, F., Escud\u00e9, C. & Boudier, T. TANGO: a generic tool for high-throughput 3D image analysis for studying nuclear organization. Bioinformatics 29, 1840\u20131841 (2013).","journal-title":"Bioinformatics"},{"key":"1871_CR113","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","volume":"177","author":"MS Ioannou","year":"2019","unstructured":"Ioannou, M. S. et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell 177, 1522\u20131535 (2019).","journal-title":"Cell"},{"key":"1871_CR114","doi-asserted-by":"publisher","first-page":"jcs263983","DOI":"10.1242\/jcs.263983","volume":"138","author":"LF Rubio-Atonal","year":"2025","unstructured":"Rubio-Atonal, L. F. et al. Glutamate decreases oxidative stress and lipid droplet formation in astrocytes. J. Cell Sci. 138, jcs263983 (2025).","journal-title":"J. Cell Sci."},{"key":"1871_CR115","first-page":"00847","volume":"25","author":"I Ralhan","year":"2025","unstructured":"Ralhan, I. et al. Protective ApoE variants support neuronal function by effluxing oxidized phospholipids. Neuron. 25, 00847\u20135 (2025).","journal-title":"Neuron."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01871-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01871-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01871-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:02:10Z","timestamp":1773687730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01871-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1871"],"URL":"https:\/\/doi.org\/10.1038\/s41556-026-01871-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.14.638390","asserted-by":"object"}]},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}